Friday, August 21, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 15.5
The index shows a bifurcated tape: many mega-cap tech and cyclical names have pulled back sharply over the trailing week even after strong 30-day gains, while a cluster of energy, healthcare/pharma, and financial names are pushing to or near fresh 52-week highs with momentum sustained across both the 5-day and 30-day windows. Breadth is narrower than the index-level 30-day gains suggest, so selectivity toward names showing coincident short- and medium-term strength near their highs is warranted.
Which of today's picks to actually take, and at what size, given what you are already holding. Each pick's own Suggested Allocation sizes it in isolation; this table applies the portfolio limits — at most 20 open positions and 60% of the portfolio committed in total. Run with --capital 25000 to see these sizes as order amounts rather than percentages.
| Rank | Stock | Action | Size | Entry → Target | Notes |
|---|---|---|---|---|---|
| #1 | APA | SKIP | — | $44.20 → $46.50 stop $40.40 |
Position cap reached — 88 of 20 slots in use. |
| #2 | PFE | SKIP | — | $28.29 → $29.73 stop $26.22 |
Position cap reached — 88 of 20 slots in use. |
| #3 | BMY | SKIP | — | $66.92 → $70.35 stop $62.10 |
Position cap reached — 88 of 20 slots in use. |
| #4 | MSI | SKIP | — | $480.79 → $505.68 stop $447.61 |
Position cap reached — 88 of 20 slots in use. |
Already open: CSX (to Aug 22), WAB (to Aug 22), CSX (to Aug 22), JPM (to Aug 23), UNP (to Aug 23), CB (to Aug 24), JPM (to Aug 24), JPM (to Aug 26), CB (to Aug 27), JPM (to Aug 27), RTX (to Aug 27), WAB (to Aug 27) … and 76 more. Symbols you already hold were excluded from this run's candidates rather than re-picked.
Position-sizing guidance only — half-Kelly per pick, bounded by the limits above. Not personal investment advice.
APA Corporation is an oil and gas producer with operations in the U.S., Egypt, and emerging international projects. It just raised its production guidance and cost-savings targets after a strong quarter, and it's been paying down debt while returning cash to shareholders. The main risk is that oil and gas prices are volatile and largely out of the company's control, and the stock has already climbed nearly 24% in the past month.
Why the AI likes it
What could go wrong
Calibrated probability: 72% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Pfizer is a major global pharmaceutical company known for vaccines and a broad prescription drug lineup. It just raised its full-year revenue forecast and its CEO bought over $1 million of stock alongside two board members, both signs that people close to the company expect continued strength. The main risk is that the stock has already jumped sharply in the past month, so some of the good news may already be reflected in the price.
Why the AI likes it
What could go wrong
Calibrated probability: 72% (raw model estimate: 65%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Bristol-Myers Squibb develops and sells prescription drugs for cancer, heart disease and other conditions. Its shares have been steadily climbing and are beating the broader market, with healthy — not overheated — technical readings suggesting room to keep running. The main risk is a broad pullback in healthcare stocks or an unexpected drug-related setback.
Why the AI likes it
What could go wrong
Calibrated probability: 72% (raw model estimate: 69%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Motorola Solutions makes communication and public-safety technology used by police and emergency services. The stock has climbed steadily and is beating the broader market, with a healthy technical setup. The main risk is that short-term buying momentum has slowed and trading volume isn't fully confirming the rally.
Why the AI likes it
What could go wrong
Calibrated probability: 72% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by September 20, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 28 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.